[Syncope by volley of ventricular spikes induced or encouraged by prenylamine].
D000368:Aged; D001572:Benzofurans / Q000627:therapeutic use; D001919:Bradycardia / Q000209:etiology; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000209:etiology; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008991:Monitoring, Physiologic; D010078:Oxazines / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011189:Potassium Chloride / Q000627:therapeutic use; D011299:Prenylamine / Q000009:adverse effects*; D011379:Prognosis; D011802:Quinidine / Q000009:adverse effects; D013575:Syncope / Q000188:drug therapy / Q000209:etiology; D013610:Tachycardia / Q000150:complications* / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000150:complications
D001572:Benzofurans; D004338:Drug Combinations; D010078:Oxazines; D011189:Potassium Chloride; D011802:Quinidine; D011299:Prenylamine; D007545:Isoproterenol
Syncopes par torsades de pointes induites ou favorisées par la prénylamine.